Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

Genetic variation at the chromosome 9p21 risk locus promotes cardiovascular disease; however, it is unclear how or which proteins encoded at this locus contribute to disease. We have previously demonstrated that loss of one candidate gene at this locus, cyclin-dependent kinase inhibitor 2B (Cdkn2b),...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kojima, Yoko, Downing, Kelly, Kundu, Ramendra, Miller, Clint, Dewey, Frederick, Lancero, Hope, Raaz, Uwe, Perisic, Ljubica, Hedin, Ulf, Schadt, Eric, Maegdefessel, Lars, Quertermous, Tom, Leeper, Nicholas J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938254/
https://ncbi.nlm.nih.gov/pubmed/24531546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI70391
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak